Strengthening the Access to Rare Disease Treatment in India

Orchestrating Collaborative Actions to Generate Rare Disease Crowdfunding Takeda and United Nations Global Compact Network of India (UNGCNI) Join Hands Bangalore, 9 May 2022: In November 2021, Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, together with UNGCNI launched a national initiative for improving early access to treatment for Rare Disease Patients in

Related Keywords

Kolkata ,West Bengal ,India ,Bangalore ,Karnataka ,Lucknow ,Uttar Pradesh ,Mumbai ,Maharashtra ,New Delhi ,Delhi ,Bharat ,Serina Fischer ,Ruchi Sogarwal ,Somnath Singh ,Ajeet Kumar Sharma ,Aseem Kumar ,United Nations Global Compact Network Of India ,Government Notified Centre Of Excellences ,Bharat Petroleum ,Department Of Public Enterprises ,Ministry Of Health ,Political Declaration On Universal Health Coverage ,Kerala State Legal Services Authority ,Takeda Pharmaceutical Company ,Good Health ,Ministry Of Corporate Affairs ,Public Affairs Patient Advocacy ,Centers Of Excellence ,Sustainable Development Goals ,National Policy For Rare ,Bharat Heavy Electricals Ltd ,Orchestrating Collaborative Actions ,Generate Rare Disease ,United Nations Global Compact Network ,Takeda Pharmaceutical Company Limited ,Rare Disease Patients ,India Rare Disease ,Corporate Affairs ,Public Enterprises ,Family Welfare ,Corporate Leaders ,Officiating Executive Director ,Political Declaration ,Universal Health ,General Manager ,Takeda India ,Head Public Affairs ,Patient Advocacy ,Bharat Heavy Electricals ,National Policy ,Government Notified Centre ,Improving Early Access ,Programme Manager ,